Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Viale, G; Regan, M M; Dell'Orto, P; Mastropasqua, M G; Maiorano, E; Rasmussen, B B; MacGrogan, G; Forbes, J F; Paridaens, R J; Colleoni, M; Láng, I; Thürlimann, B; Mouridsen, H; Mauriac, L; Gelber, R D; Price, K N; Goldhirsch, A; Gusterson, B A; Coates, A S; BIG 1-98 Collaborative and International Breast Cancer Study Groups
2011
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Colleoni, M; Sun, Z; Martinelli, G; Basser, R L; Coates, A S; Gelber, R D; Green, M D; Peccatori, F; Cinieri, S; Aebi, S; Viale, G; Price, K N; Goldhirsch, A; International Breast Cancer Study Group
2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
Annals of oncology : official journal of the European Society for Medical Oncology
Chirgwin, Jacquie; Sun, Zhuoxin; Smith, Ian; Price, Karen N; Thürlimann, Beat; Ejlertsen, Bent; Bonnefoi, Hervé; Regan, Meredith M; Goldhirsch, Aron; Coates, Alan S; BIG 1-98 Collaborative and International Breast Cancer Study Groups
2012
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
Strasser, Florian; Lutz, Thomas A.; Maeder, Micha T.; Thuerlimann, Beat; Buechel, David; Tschöp, Matthias H.; Kaufmann, Katrin; Holst, B.; Brändle, Michael; von Moos, Roger; Demmer, Ruth; Cerny, Thomas
2008
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
Strasser, Florian; Lutz, Thomas A.; Maeder, Micha T.; Thürlimann, Beat; Büche, D.; Tschöp, M.; Kaufmann, Karin; Holst, B.; Brändle, Michael; von Moos, Roger; Demmer, Ruth; Cerny, Thomas
2008
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double blind, douple-crossover study
Bernhard, J; Zahrieh, D; Zhang, J J; Martinelli, G; Basser, R; Hürny, C; Forbes, J F; Aebi, S; Yeo, W; Thürlimann, B; Green, M D; Colleoni, M; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Goldhirsch, A; Coates, A S; International Breast Cancer Study Group
2008
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
Viale, Giuseppe; Giobbie-Hurder, Anita; Regan, Meredith M; Coates, Alan S; Mastropasqua, Mauro G; Dell'Orto, Patrizia; Maiorano, Eugenio; MacGrogan, Gaëtan; Braye, Stephen G; Ohlschlegel, Christian; Neven, Patrick; Orosz, Zsolt; Olszewski, Wojciech P; Knox, Fiona; Thürlimann, Beat; Price, Karen N; Castiglione-Gertsch, Monica; Gelber, Richard D; Gusterson, Barry A; Goldhirsch, Aron; Breast International Group Trial 1-98
2008
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer : results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine : a randomized, placebo-controlled, double-blind study
